SCHEMBL6962964

SCHEMBL6962964

Cc1ccc(S(=O)(O)=S)cc1CCc1ccccc1Cl

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 1/20 0.43
LMNA P02545 3/20 0.38
KMT2A Q03164 1/20 0.38
ALDH1A1 P00352 4/20 0.38
POLB P06746 3/20 0.38
THRB P10828 1/20 0.38
KCNJ6 P48051 1/20 0.38
KCNJ5 P48544 1/20 0.38
KCNJ3 P48549 1/20 0.38
TP53 P04637 1/20 0.38
TAAR1 Q96RJ0 3/20 0.37
MAPK1 P28482 1/20 0.37
DAO P14920 1/20 0.37
HPGD P15428 1/20 0.36
HDAC8 Q9BY41 1/20 0.36
GAA P10253 1/20 0.36
MAPT P10636 1/20 0.36
SLC6A2 P23975 1/20 0.36
SLC6A4 P31645 1/20 0.36
SLC6A3 Q01959 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6604221 0.90 PTGS2 (0.44) PTGS2LMNAKMT2AALDH1A1POLB
SCHEMBL6962958 0.83 PTGS2 (0.45) PTGS2LMNAKMT2AALDH1A1POLB
SCHEMBL6604230 0.83 ALDH1A1 (0.41) LMNAKMT2AALDH1A1POLBGAA
SCHEMBL10886550 0.79 FFAR4 (0.38) LMNAALDH1A1TAAR1MAPT
SCHEMBL6603886 0.78 TDP1 (0.41) LMNAKMT2AALDH1A1POLBHPGD
SCHEMBL6959651 0.78 KMT2A (0.42) LMNAKMT2AALDH1A1POLBHPGD
SCHEMBL6605344 0.76 TDP1 (0.42) LMNAKMT2AALDH1A1THRB
SCHEMBL6605223 0.75 TAS2R14 (0.41) PTGS2LMNAKMT2AALDH1A1POLB
SCHEMBL6962962 0.75 TAAR1 (0.41) PTGS2LMNAKMT2AALDH1A1POLB
SCHEMBL10596213 0.73 ALDH1A1 (0.41) LMNAALDH1A1TAAR1HPGDGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0729465-B1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE DAVIS & CO (US) 2003-01-22 EP disclosed
US-6005103-A TREATMENT OF BACTERIAL AND VIRAL INFECTIONS AND DISEASES, INCLUDING AIDS WARNER-LAMBERT COMPANY (US) 1999-12-21 US disclosed
US-5808062-A AIDS THERAPY WARNER-LAMBERT COMPANY (US) 1998-09-15 US disclosed
EP-0729466-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
EP-0729465-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
WO-1995014013-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed
WO-1995014014-A2 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed